Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2014 (2014), Article ID 251423, 3 pages
http://dx.doi.org/10.1155/2014/251423
Case Report

Reactivation of Cutaneous Leishmaniasis after Renal Transplantation: A Case Report

1Department of Dermatology, Tehran University of Medical Sciences, Razi Hospital, Vahdat Islamic Square, Tehran 1199663911, Iran
2Department of Pathology, Tehran University of Medical Sciences, Razi Hospital, Vahdat Islamic Square, Tehran 1199663911, Iran

Received 30 September 2013; Accepted 12 December 2013; Published 16 January 2014

Academic Editors: H. Dobrev, H. Silm, and M. Vaccaro

Copyright © 2014 Hossein Mortazavi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Ponte-Sucre, “Introduction: leishmaniasis—the biology of a parasite,” in Drug Resistance in Leishmania Parasites, A. Ponte-Sucre, E. Diaz, and M. Padrón-Nieves, Eds., Springer, Vienna, Austria, 2013. View at Google Scholar
  2. S. Mendez, S. K. Reckling, C. A. Piccirillo, D. Sacks, and Y. Belkaid, “Role for CD4+ CD25+ regulatory T cells in reactivation of persistent Leishmaniasis and control of concomitant immunity,” Journal of Experimental Medicine, vol. 200, no. 2, pp. 201–210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Asilian, A. Sadeghinia, G. Faghihi, and A. Momeni, “Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) versus cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis,” International Journal of Dermatology, vol. 43, no. 4, pp. 281–283, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. P. Cannavò, M. Vaccaro, and F. Guarneri, “Leishmaniasis recidiva cutis,” International Journal of Dermatology, vol. 39, no. 3, pp. 205–206, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. J. H. S. Pettit and L. C. Parish, Manual of Tropical Dermatology, Springer, New York, NY, USA, 1st edition, 1984.
  6. D. Weedon, Weedon's Skin Pathology, Elsevier, 3rd edition, 2010.
  7. R. T. Czechowicz, T. P. Millard, H. R. Smith, R. E. Ashton, S. B. Lucas, and R. J. Hay, “Reactivation of cutaneous leishmaniasis after surgery,” British Journal of Dermatology, vol. 141, no. 6, pp. 1113–1116, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Mirzabeigi, U. Farooq, S. Baraniak, L. Dowdy, G. Ciancio, and V. Vincek, “Reactivation of dormant cutaneous Leishmania infection in a kidney transplant patient,” Journal of Cutaneous Pathology, vol. 33, no. 10, pp. 701–704, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Zandieh, B. Zandieh, and L. Dastgheib, “Dissemination of localized cutaneous leishmaniasis in an organ transplant recipient: case report and literature review,” International Journal of Dermatology, vol. 52, pp. 59–62, 2013. View at Google Scholar
  10. F. F. Tuon, V. S. Amato, L. M. Floeter-Winter et al., “Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids - First report,” International Journal of Dermatology, vol. 46, no. 6, pp. 628–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Borgia, M. Vaccaro, F. Guarneri, C. Manfrè, S. P. Cannavò, and C. Guarneri, “Mucosal leishmaniasis occurring in a renal transplant recipient,” Dermatology, vol. 202, no. 3, pp. 266–267, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Broeckaert-van Orshoven, P. Michielsen, and J. Vandepitte, “Fatal leishmaniasis in renal-transplant patient,” The Lancet, vol. 2, no. 8145, pp. 740–741, 1979. View at Google Scholar · View at Scopus
  13. I. Simon, K. M. Wissing, V. Del Marmol et al., “Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature,” Transplant Infectious Disease, vol. 13, no. 4, pp. 397–406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Rousseau, I. Suffia, B. Ferrua, P. Philip, Y. Le Fichoux, and J. Kubar, “Prolonged administration of dexamethasone induces limited reactivation of visceral leishmaniosis in chronically infected BALB/c mice,” European Cytokine Network, vol. 9, no. 4, pp. 655–661, 1998. View at Google Scholar · View at Scopus
  15. C. Guarneri, M. Vaccaro, S. P. Cannavò, F. Borgia, and B. Guarneri, “Erythematous-edematous-infiltrative plaque on the face: cutaneous angio-lupoid leishmaniasis,” European Journal of Dermatology, vol. 12, no. 6, pp. 597–599, 2002. View at Google Scholar · View at Scopus